 | |
| Type | Public (SIX: NOVN, NYSE: NVS) |
|---|---|
| Founded | 1996 (from merger) |
| Headquarters | Basel, Switzerland |
| Key people | Daniel Vasella (Chairman of the board and CEO) |
| Industry | Pharmaceutical industry |
| Products | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...) |
| Revenue | US $44.27 billion (2009)[1] |
| Operating income | ▲ US $9.98 billion (2009)[1] |
| Net income | ▲ US $8.40 billion (2009)[1] |
| Employees | 99,830 (FTE, 2009)[1] |
| Subsidiaries | Ciba Vision, Sandoz |
| Website | www.novartis. com |
|
|
No comments:
Post a Comment